Parallel Trade - US Lawmakers allow imported prescriptions drugs

Questions: Discounts, Updates etc.

Pages: 143

Price (Single): £1,499

Price (Departmental): £2,999

Price (Company): £4,999

Publication Date: 2007-06-21

Order Online Now

People that purchased this report also purchased:

Contact LeadDiscovery

  • If you have questions about this report
  • To find out if you qualify for a discount
  • Want a more up to date version
  • Can't find a report that meets your needs
Search all reports

Keywords:

Boolean terms AND, OR, NOT can be used. Phrases should be entered within quotes. For wildcards use an *


"Parallel Trade acts as an important driving force for market integration where there are important differences in price between member states"

- European Commission Communication on the single market in pharmaceuticals

Parallel trade is on the verge of breaking its confines of the EU and diffusing into other global markets. This global practice is far from simple, and the loopholes that have made it possible refuse to close. Whether you think parallel trade is a benefit or a cost, the reality is that it is affecting the whole pharma industry on a wide scale. It started out a North-South divide but even this is changing. The European Commission and other trade regulation bodies won't protect the pharma companies pricing structures.

Although consumers may think that imported drugs into the US come from Canada, UK, or other Western European nations, it's impossible to definitively verify an imported drug's country of origin.

  • Do developing countries see parallel trade as a benefit for cheap drugs and if so will it remain a benefit?
  • This year how much will pharma companies' profits be threatened by parallel trade?
  • With individual drugs already being bought in Canada and Mexico will large scale parallel trade become a reality in the US as there are no price controls in place?
  • The US market is such an attractive market for parallel traders. How will the enlargement of the EU, to 27 affect parallel trade?

Patients, general practitioners, healthcare agencies and national governments are all benefiting from this gray market import. However, there are actual ˜real' winners in this trade, parallel traders themselves. They gain the most benefit from such a trade, which is pure profit. On the other hand, pharma companies are blaming parallel trade, for huge losses in revenue, which in affect lowers innovation. Parallel trade is seen as a gateway for counterfeit drugs entering the supply chain.

"In the European Union, products pass freely from one member nation to another” through a system called 'parallel trade.' Consequently, drugs sold in England may actually have originated in a country with less rigorous safety standards, such as Cyprus or Latvia". Warwick News

The latest case of counterfeit drugs entering the UK supply chain was that of Eli Lilly's antipsychotic drug, Zyprexa and Sanofi-Aventis and Bristol Myers Squibb's Plavix. Three batches were recalled by the MHRA. Isn't this enough evidence that parallel trade is having a negative affect on the pharma industry? Find out by buying this report.

Does parallel trade diminish the quality and safety of drugs? Isn't repackaging a great issue when it comes to parallel trade? Isn't the Internet is a great medium for a form of parallel trade? Many important questions that need answers.

Why You Must Buy This Report:

This 130+ paged report features key figures, including graphs and charts, important tables, news, insights, the latest developments in the parallel trade market with up-to-date analysis.

This report will give you the understanding you require to gain that competitive edge in the parallel trade market. This controversial practice is a hot topic in the pharma industry. Therefore, it is vital that the latest parallel trade report is brought without fail.

With in depth analysis of key markets, and the latest information on parallel trade, this report is vital to grasp an understanding of parallel trade.

Key questions that this report answers:

  • Why aren't regulatory bodies protecting pharma companies from parallel trade?
  • What are the affects of parallel trade on each segment of the market?
  • Is it possible for pharma companies to protect themselves legally from?
  • What price link can pharma companies establish that will halt parallel trade without reducing profits further?
  • What liability do pharma companies face through repackaging when aligned with parallel trade?
  • How can big pharma use the internet to combat parallel trade?
  • How does parallel trade (re-importation) affect the US and Canada?

Table of Contents

  • Chapter 1. Executive Summary: Parallel Trade, Benefiting or Breaking the Pharma Industry?
  • Chapter 2. Parallel Trade in Global Pharmaceutical Industry

  • Chapter 3. Legal Aspects of Parallel Trade

  • Chapter 4. Price is the Principal Driver of Parallel Trade

  • Chapter 5. Parallel Trade in US and Canada

  • Chapter 6. Parallel Trade in Europe

  • Chapter 7. The Role of the Internet in Parallel Trade

  • Chapter 8. Counterfeiting is a Major Threat

  • Chapter 9. The Issue of Repackaging

  • Chapter 10. Arguments for Parallel Trade

  • Chapter 11. Arguments Against Parallel Trade

  • Chapter 12. Parallel Trade: Double Edged Sword

  • List of Tables
  • Table 2.1 R&D Expenditure in the UK ($m)
  • Table 4.1 Comparative Drug Prices in Selected Developed Countries
  • Table 4.2 All Factors that Influence Drug Prices
  • Table 4.3 Pricing Differentials for Leading Drugs (30 day supply)
  • Table 4.4 Another Example of Differential Pricing (price per pill)
  • Table 4.5 Advantages and Disadvantages of Single European Price
  • Table 5.1 Difference in Pricing of Selected Drugs
  • Table 5.2 U.S./Canadian Price Comparisons
  • Table 5.3 Price Per Standard Unit in the US Compared to Canada
  • Table 5.4 Price Per Standard Unit of Lipitor in the US and Canada
  • Table 5.5 Price Difference in Selected Generics
  • Table 6.1 Key Financials for the EU Pharmaceutical Industry ($m), 1990-2005
  • Table 6.2 EU Pharmaceutical Trade Balances ($m)
  • Table 6.3 Price Per Standard Unit in EU States
  • Table 6.4 Price Per Standard Unit of Lipitor in EU States
  • Table 6.5 NHS Saving Compared to Parallel Importers' Profit
  • Table 6.6 UK Parallel Distributors
  • Table 6.7 German Parallel Importers
  • Table 6.8 Swedish Parallel Traders
  • Table 6.9 Norwegian Parallel Importers
  • Table 7.1 Internet Usage World Wide
  • Table 7.2 Top 20 Countries in Regards to Internet Usage
  • Table 7.3 World Online Drug Market
  • Table 7.4 US Agencies and their Authorities
  • Table 7.5 Differences between Rogue and Quality Sites
  • Table 8.1 Top Ranked Countries where Counterfeits were Seized/Discovered
  • Table 10.1 Estimated Total Direct Savings from Parallel Trade in 2002
  • Table 10.2 Estimated Direct Savings in 2004
  • List of Graphs
  • Graph 1.1 Global R&D Expenditure and NME output
  • Graph 4.1 Incidents in Europe
  • Graph 5.1 World Internet Usage
  • Graph 5.2 Top 20 Internet Usage Countries
  • Graph 5.3 World Online Drug Market ($bn)
  • Graph 7.1 European Parallel Trade
  • Graph 7.2 EU Pharma Trade Balances
  • Graph 7.3 Share of Parallel Imports in Pharmacy Market Sales (%)
  • Graph 7.4 Estimated Share of Parallel Imports in Pharmacy Market Sales (%), 2007
  • List of Figures
  • Figure 1.1 Parallel Trading
  • Figure 3.1 Cost of Production
  • Figure 3.2 Inelastic Market
  • Figure 3.3 Elastic Market

    • Other users found this report page using the following search terms: Parallel Trade parallel trade drugs us pharmaceutical import imports uk imported european

    If you can't find a report that meets your needs contact LeadDiscovery. We are one of the few report providers with extensive drug development experience and we frequently use this knowledge to help clients source the most appropriate reports or produce reports for them from scratch.


    Refund and Cancellation Policy: The descriptions of the products and services sold on LeadDiscovery.co.uk are as complete and accurate as possible, and customers are encouraged to read all available information about a product before placing an order. Due to the nature of the information being sold, orders for reports cannot be canceled.